Researcher.Life Logo

ARS PHARMACEUTICA : Impact Factor & More

eISSN: 2340-9894pISSN: 0004-2927
JournalOpen Access
Recommended pre-submission checks
Powered by Paperpal by Editage

ARS PHARMACEUTICA Journal Specifications

Overview
Publisher UNIV GRANADA, EDITORIAL
Language English,Spanish
Frequency Quarterly
Publication Time10
Editorial Review ProcessPeer review
General Details
LanguageEnglish,Spanish
Society/Institute/SponsorUniversidad de Granada
FrequencyQuarterly
Publication Start Year1960
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
Publication Time 10
Editorial Review Detail
Editorial TeamVisit website
Review ProcessPeer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Deposit PolicySherpa/Romeo,Dulcinea
License typeCC BY-NC-SA
OA statementVisit website
View less

Planning to publish in ARS PHARMACEUTICA ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in ARS PHARMACEUTICA

Formulation and Evaluation of Oral Disintegrating Tablets of Enalapril Maleate Using Synthetic and Natural Superdisintegrants
  • 20 Dec 2025
  • Ars Pharmaceutica (Internet)
Características clínicas y sociodemográficas de pacientes con alergia a betalactámicos: Revisión estructurada
  • 20 Dec 2025
  • Ars Pharmaceutica (Internet)
Beers, STOPP/START y PRISCUS: análisis crítico de su evolución y aplicabilidad en la prescripción geriátrica
  • 20 Dec 2025
  • Ars Pharmaceutica (Internet)
Enhanced Solubility and Dissolution of Selexipag via β-Cyclodextrin Inclusion Complexes: Formulation and Evaluation
  • 20 Dec 2025
  • Ars Pharmaceutica (Internet)
Antidepressant and anxiolytic activity of Safoof-i Sawda: A polyherbal Unani formulation in rats
  • 20 Dec 2025
  • Ars Pharmaceutica (Internet)
Mejora de la Solubilidad y del Perfil de Disolución de Loteprednol Etabonate mediante Co-Cristalización: Una Estrategia para Potenciar el Rendimiento Biofarmacéutico
  • 20 Dec 2025
  • Ars Pharmaceutica (Internet)
Formulation and Evaluation of Oral Disintegrating Tablets of Enalapril Maleate Using Synthetic and Natural Superdisintegrants
  • 20 Dec 2025
  • Ars Pharmaceutica (Internet)
Características clínicas y sociodemográficas de pacientes con alergia a betalactámicos: Revisión estructurada
  • 20 Dec 2025
  • Ars Pharmaceutica (Internet)
Beers, STOPP/START y PRISCUS: análisis crítico de su evolución y aplicabilidad en la prescripción geriátrica
  • 20 Dec 2025
  • Ars Pharmaceutica (Internet)
Enhanced Solubility and Dissolution of Selexipag via β-Cyclodextrin Inclusion Complexes: Formulation and Evaluation
  • 20 Dec 2025
  • Ars Pharmaceutica (Internet)
Antidepressant and anxiolytic activity of Safoof-i Sawda: A polyherbal Unani formulation in rats
  • 20 Dec 2025
  • Ars Pharmaceutica (Internet)
Mejora de la Solubilidad y del Perfil de Disolución de Loteprednol Etabonate mediante Co-Cristalización: Una Estrategia para Potenciar el Rendimiento Biofarmacéutico
  • 20 Dec 2025
  • Ars Pharmaceutica (Internet)

FAQs on ARS PHARMACEUTICA